Literature DB >> 6800796

Excretion of aflatoxin B1 as a glutathione conjugate.

G O Emerole.   

Abstract

Intraperitoneal injection of 3H - GSH (15.4 mg, 0,5 microCi) 15 minutes before a similar i.p. treatment with Aflatoxin B1 (AFB1) (2mg/kg) showed less than 40% of the radioactivity in the 24 h urine and 30-35% in the bile. Analysis of the urine and bile samples by TLC and separation with XAD-2, showed only traces of the AFB1 - GSH adduct present in the urine and 14% in the bile, AFB1 metabolites isolated from the urine of the 3H - GSH treated rats identical with those of rats treated with AFB1 only. While GSH Conjugate appears therefore to be a major component of biliary excretion of AFB1, it does not seem to be significant in the urinary excretion of the toxin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6800796     DOI: 10.1007/BF03189524

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  14 in total

1.  The metabolism of styrene oxide in the isolated perfused rat liver. Identification and quantitation of major metabolites.

Authors:  A J Ryan; J R Bend
Journal:  Drug Metab Dispos       Date:  1977 Jul-Aug       Impact factor: 3.922

2.  Binding of [-14C]aflatoxin B1 to cellular macromolecules in the rat and hamster.

Authors:  R C Garner; C M Wright
Journal:  Chem Biol Interact       Date:  1975-08       Impact factor: 5.192

3.  Biliary excretion of aflatoxin in the rat after a single dose.

Authors:  O Bassir; F Osiyemi
Journal:  Nature       Date:  1967-08-19       Impact factor: 49.962

4.  Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite.

Authors:  D J Jollow; J R Mitchell; N Zampaglione; J R Gillette
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

Review 5.  Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture.

Authors:  J A Miller
Journal:  Cancer Res       Date:  1970-03       Impact factor: 12.701

Review 6.  Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: a review.

Authors:  P M Newberne; W H Butler
Journal:  Cancer Res       Date:  1969-01       Impact factor: 12.701

7.  Chemical evidence for the formation of a reactive aflatoxin B1 metabolite, by hamster liver microsomes.

Authors:  R C Garner
Journal:  FEBS Lett       Date:  1973-11-01       Impact factor: 4.124

Review 8.  Mechanisms of chemical carcinogenesis: nature of proximate carcinogens and interactions with macromolecules.

Authors:  E C Miller; J A Miller
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

9.  Excretion and tissue distribution of radioactivity from aflatoxin B1-14-C in rats.

Authors:  G N Wogan; G S Edwards; R C Shank
Journal:  Cancer Res       Date:  1967-10       Impact factor: 12.701

10.  The detoxication of aflatoxin B1 with glutathione in the rat.

Authors:  G O Emerole; N Neskovic; R L Dixon
Journal:  Xenobiotica       Date:  1979-12       Impact factor: 1.908

View more
  2 in total

1.  Association of Aflatoxin and Gallbladder Cancer.

Authors:  Jill Koshiol; Yu-Tang Gao; Michael Dean; Patricia Egner; Chirag Nepal; Kristine Jones; Bingsheng Wang; Asif Rashid; Wen Luo; Alison L Van Dyke; Catterina Ferreccio; Michael Malasky; Ming-Chang Shen; Bin Zhu; Jesper B Andersen; Allan Hildesheim; Ann W Hsing; John Groopman
Journal:  Gastroenterology       Date:  2017-04-17       Impact factor: 22.682

Review 2.  Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer.

Authors:  Pablo Pérez-Moreno; Ismael Riquelme; Patricia García; Priscilla Brebi; Juan Carlos Roa
Journal:  J Pers Med       Date:  2022-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.